Analyst Price Target is $0.00
This price target is based on 0 analysts offering 12 month price targets for Smith & Nephew in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.
Current Consensus is
The current consensus among 0 contributing investment analysts is to n/a stock in Smith & Nephew. This N/A consensus rating has held steady for over two years.
Sunniva Inc., a vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States. The company operates through Patient Counselling, Merchandising, and Cultivation & Extraction segments. It offers its products under the Sun Fire, Kyndness, and Herbella brands. The company was formerly known as Sunniva Holdings Corp. and changed its name to Sunniva Inc. in August 2017. Sunniva Inc. was founded in 2014 and is headquartered in Vancouver, Canada.